Day: November 5, 2024

Posted on

COIN DEADLINE ALERT: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Coinbase Global, Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action First Filed by the Firm – COIN

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Coinbase Global, Inc. (NASDAQ: COIN) between April 14, 2021 and July 25, 2024, both dates inclusive (the “Class Period”), of the important November 12, 2024 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased Coinbase securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Coinbase class action, go to https://rosenlegal.com/submit-form/?case_id=28116 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 12, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) in 2020, the United Kingdom’s Financial Conduct Authority (“FCA”) had deemed efforts by Coinbase’s British unit, CB Payments Limited (“CBPL”), to prevent criminals from using its platform, to be inadequate; (2) as a result, the FCA reached an agreement with CBPL, which put requirements in place that were designed to prevent high risk customers from using CBPL’s platform; (3) CBPL then breached that agreement, which resulted in 13,416 high risk individuals receiving services; (4) the foregoing resulted in an undisclosed heightened regulatory risk; and (5) as a result, defendants statements about its business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Coinbase class action, go to https://rosenlegal.com/submit-form/?case_id=28116 call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 9267832

Posted on

Pangea Launches Two New Advanced Materials

Pulvera & Verita Offer Industry-Leading Luxury with Reduced Environmental Impact

Pangea Verita – Automotive Leather

92% Bio-Based Seat Material

ROCHESTER, Mich., Nov. 05, 2024 (GLOBE NEWSWIRE) — Pangea, a leading innovator in sustainable materials for the automotive industry, proudly announces the launch of two groundbreaking products: Pulvera and Verita. These advanced automotive leathers represent a bold step in Pangea’s ongoing commitment to sustainability and responsible manufacturing practices, aligning with the company’s vision of creating eco-friendly materials that meet the needs of a changing world.

In 2024, Pangea’s global teams set out to design a new class of leather materials specifically for the automotive industry. These products are not only nearly 90% bio-based in their finished state but also actively divert materials from landfills, dramatically reducing waste in an innovative way.

Pangea Pulvera – Automotive Leather

Luxury Seat Material at 40% Lower GWP

“Nothing Replaces Real: Charting the Path to a Zero-Waste Future”
As part of the Pangea Corporate Trend Show series, Pangea introduced “Chart the Path,” a key chapter in the company’s sustainability journey. Engaging with customers, Pangea outlined how durable, natural materials are transforming the automotive industry while aligning with global sustainability goals. The highlight of the series was the launch of Pulvera and Verita, two new product offerings that set new benchmarks for lower environmental impact, innovative recycled chemistry, and reduced Global Warming Potential (GWP).

Introducing Pangea Pulvera: Ecological Leather with a Circular Process
Pulvera is a full-bodied leather that embraces a circular manufacturing process. By incorporating a recycled compound made from buffing waste, Pulvera significantly reduces its environmental footprint. This unique process, which utilizes water and renewable energy, transforms leather waste into a valuable resource that replaces nearly half of the chemicals used in dyeing and softening the leather.

  • Renewable Chemistry: 29% of all chemicals used
  • Recycled Chemistry: 37% in the retanning process; 16% of all chemicals overall
  • Environmental Impact: Global Warming Potential (GWP) impact up to 40% lower than traditional retanning processes

Pulvera stands out as a luxurious, sustainable material that exemplifies Pangea’s commitment to eco-friendly innovations in automotive interiors.

Pangea Advanced Products

Charting the Path towards Sustainable Materials

Introducing Pangea Verita: Lavish, Compostable Leather with Low Environmental Impact

Pangea Verita elevates the art of leather craftsmanship by creating a compostable substrate through an alternative metal-free tanning process. This semi-aniline material highlights the natural beauty of the animal hide with minimal coating, emphasizing its unique characteristics while maintaining a lower environmental footprint.

  • Renewable Chemistry: 45% of all chemicals used
  • Global Warming Potential (GWP): Up to 12% lower than standard chrome-tan substrates
  • Biogenic Carbon: 92% bio-based as a finished product

Verita’s innovative design and sustainable chemistry enable a higher biogenic carbon content, enhancing its alignment with a circular economy and reducing its overall impact on the environment.

Building a Sustainable Future with Bio-Based Materials
Pangea’s new products, Pulvera and Verita, showcase how high bio-based content materials can revolutionize the automotive industry without compromising performance. With traditional Pangea leathers already achieving 80-85% bio-based content, Pulvera and Verita push these boundaries further, reaching up to 92% bio-based in their end products.

These advancements reinforce Pangea’s belief that leather, as a natural and highly renewable material, plays a vital role in creating a more sustainable future for the automotive industry. By increasing the use of bio-based resources, Pangea is dedicated to reducing the carbon footprint of its products and contributing to a healthier planet.

About Pangea

Pangea is a global leather supplier to the world’s leading automotive brands, providing sustainable solutions that drive the future of interiors. Headquartered in Rochester Hills, Michigan, Pangea serves its customers on four continents with 3,000 team members. For more information, visit www.pangeamade.com, and follow us on LinkedIn.

Media Contact

Jacquelyn Smith, Pangea
248-436-2200
jsmith@pangeamade.com

Media Attachments

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/f2c32e02-b825-4e44-b87b-5fcfbc759fb9

https://www.globenewswire.com/NewsRoom/AttachmentNg/cfcc917f-8319-4571-abc1-dcaf4ace7bd1

https://www.globenewswire.com/NewsRoom/AttachmentNg/15726cd1-c6fc-4161-ba24-17c08a2649d8

A video accompanying this announcement is available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/0f84f732-42fd-47eb-8f17-dd74c3bfdb4a  

GlobeNewswire Distribution ID 9266963

Posted on

Anryton Introduces MOL Utility Coin on XT.com with Quantum-Resistant Data Protection through its Decentralized Data Storage Platform

This launch comes at a crucial time for digital security and data ownership, as Anryton’s blockchain network and MOL coin redefine standards in privacy, scalability, and secure healthcare solutions

DUBAI, United Arab Emirates, Nov. 05, 2024 (GLOBE NEWSWIRE) — Anryton Technologies proudly announces the official launch of its Layer One blockchain network, featuring cutting-edge solutions for data ownership, security, scalability, and privacy. This landmark achievement coincides with the listing of Anryton’s native cryptocurrency, MOL, as a utility coin on XT.com, a trusted cryptocurrency exchange known for its user-centric platform. Together, these advancements underscore Anryton’s commitment to building a more secure, decentralized digital future, setting new standards in blockchain technology.

Redefining Blockchain for Privacy and Security

Anryton’s Layer One network addresses some of the most pressing challenges in blockchain today, including scalability, high transaction fees, and vulnerability to cyber threats. With rapid transactions and reduced fees, this platform is poised to support a range of applications in finance, healthcare, and beyond.

“Our Layer One Network redefines blockchain by prioritizing security, scalability, and user empowerment,” said Sidharth Bhinder, CTO of Anryton Technologies. “With quantum-resistant encryption and advanced data verification, we’re addressing modern digital threats, from quantum computing to AI-driven fraud. Listing MOL on XT.com furthers our reach, making secure decentralized finance accessible to a global audience. This launch isn’t just technological-it’s a step toward a safer, more transparent, and decentralized future.”

Dr. Anmol Kapoor, Founder of Anryton Technologies, highlighted Anryton’s mission: “A few years ago, we encountered significant concerns among Native American communities around genetic data privacy, as certain companies had misused genetic information. That inspired us to explore blockchain as a solution for data protection, identity management, and privacy-leading to the innovations we’re unveiling today.”

Introducing MOL Utility Coin and Blockchain Innovation

The MOL coin, named for its meaning “Means of Value” in multiple South Asian languages, introduces a new paradigm in decentralized finance and data control. MOL is aligned with Anryton’s mission to provide culturally resonant, inclusive solutions in a secure digital currency.

“Our goal was to create a solution that enables the collection and use of diverse genetic data for humanity’s benefit while protecting individual rights,” explained Dr. Kapoor. “We explored various blockchain options before developing our proprietary blockchain. Innovations like our DNA NFT-based Digital Data Storage Wallet allow users to secure and manage their WGS data within a decentralized, user-defined environment.”

With the listing of MOL on XT.com, Anryton brings this secure solution to a global audience, emphasizing that data ownership must belong to the individuals it concerns.

The MOL Coin
MOL Coin

Anryton’s native cryptocurrency, MOL coin (meaning “Means of Value” in Punjabi, Urdu, and Hindi)

Tackling Quantum and AI-Driven Cyber Threats

Anryton’s Layer One network incorporates quantum-resistant encryption to safeguard data against future advancements in quantum computing and AI.

“When we looked at potential risks, we realized we needed to go beyond existing solutions,” Dr. Kapoor noted. “Our goal was to create a system that not only protects data but also prioritizes security in identity management—especially in healthcare. Today, with Anryton’s technology, users have access to a resilient and adaptable system designed to withstand AI-driven fraud and quantum threats.”

HIPAA compliance is a cornerstone of Anryton’s healthcare solutions. “Patients deserve privacy and security against data breaches and identity fraud,” said Dr. Kapoor. “Our HIPAA-compliant network offers trusted regulatory standards that place patient security at the core, empowering individuals to retain control over their digital identities.”

“The MOL utility coin represents our commitment to enabling secure management of assets and identities worldwide,” added Bhinder. “With MOL and our blockchain network, users can trust that their data, identity, and digital assets are under their control.”

A Vision for Patient-Owned Healthcare

Anryton’s blockchain ecosystem, coupled with MOL, aims to revolutionize how healthcare data is managed, giving patients control over their information. “The vision is simple yet transformative: healthcare data belongs to patients. They should have access to it, and if it’s monetized, they should benefit,” said Dr. Kapoor. “Anryton empowers patients to drive health sciences forward for the common good.”

Anryton’s blockchain infrastructure includes pioneering applications like BioChain with more innovative solutions on the horizon. These tools are built to secure data, enable safe exchange, and empower patients as never before.

Celebrating Progress and a Patient-Centric Future

Launching during Diwali week, Anryton’s listing of MOL on XT.com symbolizes a new era of patient-owned healthcare and secure digital ecosystems. “This is just the beginning,” said Dr. Kapoor. “Congratulations to our team. We’ll keep challenging the status quo and unlocking new possibilities for humanity.”

Anryton’s launch of its Layer One network and the MOL utility coin on XT.com reinforces its dedication to advancing blockchain with a focus on security, accessibility, and privacy. This launch is only the beginning as the company continues to push the boundaries of what decentralized technology can achieve.

“For us, technology should serve the people, not work against them,” Bhinder concluded. “By providing a secure platform with MOL and our Layer One network, we’re paving the way for a future where data is safeguarded, privacy is prioritized, and users have control over their digital lives.”

Anryton is poised to make a lasting impact in sectors that depend on secure, transparent digital transactions.

For more information on Anryton’s blockchain network and the MOL utility coin, visit www.anryton.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/52b81bdc-f718-4f0b-b4e0-f4542823a451

info@anryton.com
403-250-2221


GlobeNewswire Distribution ID 9267428

Posted on

‫Anryton تطرح عملة MOL المساعِدَة على XT.com مع ميزة حماية البيانات المقاومة للحوسبة الكمية عبر منصتها لتخزين البيانات اللامركزية

يأتي هذا الإطلاق في وقت حاسم بالنسبة إلى الأمان الرقمي وملكية البيانات، حيث تعيد شبكة البلوك تشين وعملة MOL من Anryton صياغة معايير الخصوصية وقابلية التوسع وحلول الرعاية الصحية الآمنة

 دبي، الإمارات العربية المتحدة،, Nov. 05, 2024 (GLOBE NEWSWIRE) — أعلنت شركة Anryton Technologies بفخر عن الإطلاق الرسمي لشبكة البلوك تشين Layer One الخاصة بها، والتي تتميز بحلول متطورة لملكية البيانات وأمانها وقابليتها للتوسع والخصوصية. يتزامن هذا الإنجاز التاريخي مع إدراج عملة Anryton الرقمية الأصلية MOL‏ كعملة مساعدة على XT.com، بورصة العملات الرقمية الموثوقة المعروفة بمنصتها التي تركز على المستخدم. وتؤكد هذه التطورات معًا على التزام شركة Anryton ببناء مستقبل رقمي أكثر أمانًا ولامركزية، ووضع معايير جديدة في تكنولوجيا سلسلة الكتل.

إعادة صياغة البلوك تشين لتحقيق الخصوصية والأمان

تُعالج شبكة Layer One من Anryton بعض التحديات الأكثر إلحاحًا في البلوك تشين حاليًا، بما في ذلك قابلية التوسع ورسوم المعاملات المرتفعة وقابلية التعرض للتهديدات الإلكترونية. وبفضل المعاملات السريعة والرسوم المخفضة، تستعد هذه المنصة لدعم مجموعة من التطبيقات في مجالات التمويل والرعاية الصحية وغير ذلك.

قال Sidharth Bhinder، رئيس قسم التكنولوجيا في شركة Anryton Technologies‏: “تعيد شبكة Layer One الخاصة بنا صياغة البلوك تشين عبر منح الأولوية للأمان وقابلية التوسع وتمكين المستخدم”. وتابع قائلًا: “من خلال التشفير المقاوم للحوسبة الكمية والتحقق المتقدم من البيانات، نتصدى للتهديدات الرقمية الحديثة، بدءًا من الحوسبة الكمية إلى الاحتيال القائم على الذكاء الاصطناعي. كما يعمل إدراج MOL على منصة XT.com على تعزيز انتشارنا، ما يجعل التمويل اللامركزي الآمن في متناول الجمهور العالمي. إن هذا الإطلاق ليس مجرد إطلاق تكنولوجي – بل هو خطوة نحو مستقبل أكثر أمانًا وشفافية ولامركزية”.

بدوره، سلّط الدكتور Anmol Kapoor، مؤسس شركة Anryton Technologies‏، الضوء على مهمة شركة Anryton إذ قال: “قبل بضع سنوات، واجهنا مخاوف كبيرة بين مجتمعات الأمريكيين الأصليين حول خصوصية البيانات الجينية، حيث أساءت بعض الشركات استخدام المعلومات الجينية. وقد ألهمنا ذلك لاستكشاف البلوك تشين كحلّ لحماية البيانات وإدارة الهوية والخصوصية ــ ما أدى إلى الابتكارات التي نكشف عنها اليوم”.

تقديم عملة MOL المساعدة وابتكار البلوك تشين

تُقدِّم عملة MOL‏، التي سُميت بهذا الاسم نسبةً إلى معناها “وسائل إضافة القيمة” بلغات جنوب آسيا المتعددة، نموذجًا جديدًا في التمويل اللامركزي والتحكم في البيانات. وتتسق MOL مع مهمة Anryton المتمثلة في توفير حلول شاملة ذات صدى ثقافي عبر عملة رقمية آمنة.

أوضح الدكتور Kapoor ذلك قائلًا: “كان هدفنا يتمثل في إيجاد حل يتيح جمع البيانات الوراثية المتنوعة واستخدامها لصالح البشرية مع حماية الحقوق الفردية في الوقت ذاته. وقد استكشفنا العديد من خيارات البلوك تشين المختلفة قبل تطوير البلوك تشين الخاصة بنا. تتيح ابتكارات مثل محفظة تخزين البيانات الرقمية للحمض النووي (DNA) المستندة إلى الرمز غير القابل للاستبدال (NFT)‏ للمستخدمين تأمين بيانات تسلسل الجينوم الكامل WGS الخاصة بهم وإدارتها ضمن بيئة لامركزية يحددها المستخدم”.

من خلال إدراج MOL على منصة XT.com‏، تُقدّم Anryton هذا الحل الآمن للجمهور العالمي، مع التأكيد على أن ملكية البيانات يجب أن تكون ملكًا للأفراد الذين تخصهم.

        The MOL Coin
PLC

Anryton’s native cryptocurrency, MOL coin (meaning “Means of Value” in Punjabi, Urdu, and Hindi)

التصدي للتهديدات السيبرانية المستندة إلى الحوسبة الكمية والذكاء الاصطناعي

تتضمن شبكة Layer One من Anryton ‏تشفيرًا مقاومًا للحوسبة الكمية لحماية البيانات من التطورات المستقبلية في الحوسبة الكمية والذكاء الاصطناعي.

أشار الدكتور Kapoor إلى ذلك قائلًا: “عندما درسنا المخاطر المحتملة، أدركنا أننا بحاجة إلى الذهاب إلى ما هو أبعد من الحلول الحالية. تمثّل هدفنا في إنشاء نظام لا يحمي البيانات فحسب، بل يمنح الأولوية كذلك للأمان في إدارة الهوية ــ لا سيما في مجال الرعاية الصحية. واليوم، بفضل تقنية Anryton، أصبح بإمكان المستخدمين الوصول إلى نظام مرن وقابل للتكيف مصمم لمكافحة الاحتيال القائم على الذكاء الاصطناعي وتهديدات الحوسبة الكمية”.

إن الامتثال لقانون قابلية نقل التأمين الصحي والمساءلة (HIPAA) هو حجر الزاوية في حلول الرعاية الصحية التي تقدمها شركة Anryton. قال الدكتور Kapoor: “يستحق المرضى الخصوصية والأمان ضد انتهاكات البيانات وتزوير الهوية. وتُوفِّر شبكتنا المتوافقة مع قانون HIPAA معايير تنظيمية موثوقة تضع أمان المرضى في الصميم، ما يمكّن الأفراد من الاحتفاظ بالسيطرة على هوياتهم الرقمية”.

أضاف Bhinder قائلًا: “تُمثِّل عملة MOL المُساعِدة التزامنا بتمكين الإدارة الآمنة للأصول والهويات حول العالم، وبفضل عملة MOL والبلوك تشين الخاصة بنا، يمكن للمستخدمين أن يثقوا في أن بياناتهم وهويتهم وأصولهم الرقمية خاضعة لسيطرتهم”.

رؤية للرعاية الصحية المملوكة للمرضى

يهدف نظام البلوك تشين من Anryton إلى جانب عملة MOL إلى إحداث ثورة في كيفية إدارة بيانات الرعاية الصحية، ما يتيح للمرضى السيطرة على معلوماتهم. قال الدكتور Kapoor في هذا الصدد: “الرؤية بسيطة لكنها تحويلية: بيانات الرعاية الصحية تعود للمرضى. ويجب أن تكون لديهم إمكانية الوصول إليها، وإذا تم استثمارها، فيجب أن يستفيدوا منها. إذ تعمل Anryton على تمكين المرضى من دفع تطور العلوم الصحية إلى الأمام من أجل الصالح العام”.

تتضمن البنية التحتية للبلوك تشين الخاصة بشركة Anryton تطبيقات رائدة مثل BioChain، مع حلول أكثر ابتكارًا تلوح في الأفق. صُممت هذه الأدوات لتأمين البيانات وتمكين التبادل الآمن لها وتمكين المرضى على نحوٍ غير مسبوق.

الاحتفال بالتقدم والمستقبل المتمحور حول المرضى

يرمز إدراج Anryton لعملة MOL، التي سيتم إطلاقها خلال أسبوع ديوالي، على منصة XT.com إلى حقبة جديدة من الرعاية الصحية المملوكة للمرضى والمنظومة الرقمية الآمنة. قال الدكتور Kapoor: “هذه هي البداية فحسب. مبارك لفريقنا. وسنواصل تحدي الوضع الراهن وإطلاق إمكانيات جديدة للبشرية”.

إن إطلاق Anryton لشبكتها Layer One وعملة MOL المساعدة على منصة XT.com يعزز تفانيها في تطوير منظومة البلوك تشين مع التركيز على الأمان وسهولة الوصول والخصوصية. وهذا الإطلاق ليس سوى البداية، حيث تواصل الشركة توسعة نطاق ما يمكن أن تحققه التكنولوجيا اللامركزية.

اختتم Bhinder حديثه قائلًا: “بالنسبة إلينا، يجب أن تخدم التكنولوجيا الناس، لا أن تعمل ضدهم. من خلال توفير منصة آمنة مزودة بعملة MOL وشبكة Layer One الخاصة بنا، فإننا نمهد الطريق لمستقبل تكون فيه البيانات محمية وتمثل الخصوصية أولوية ويتحكم فيه المستخدمون بحياتهم الرقمية”.

توشك شركة Anryton على إحداث تأثير دائم في القطاعات التي تعتمد على المعاملات الرقمية الآمنة والشفافة.

لمزيد من المعلومات حول شبكة البلوك تشين الخاصة بشركة Anryton وعملة MOL المساعدة، تفضل بزيارة www.anryton.com‏.

تتوفر صورة مصاحبة لهذا الإعلان على

https://www.globenewswire.com/NewsRoom/AttachmentNg/52b81bdc-f718-4f0b-b4e0-f4542823a451/ar

‎info@anryton.com
403-250-2221


GlobeNewswire Distribution ID 9267428

Posted on

Leonteq Launches Shari’a-Compliant Offering on LYNQS

Leonteq announced today that it has enabled its Shari’a-compliant structured product offering on its digital investing platform, LYNQS.

ZURICH, SWITZERLAND – EQS Newsroom – 5 November 2024 – Following the opening of its office in Dubai in 2021, and as part of its growth ambition to service the broader Gulf Cooperation Council (GCC) market, Leonteq has expanded its product offering with the launch of Shari’a-compliant trust certificates in 2022.
The trust certificates are issued by IBDAA Certificate Issuer Ltd. (IBDAA), a standalone special purpose vehicle company, under the Shari’a Compliant Trust Certificate Issuance and Offering Programme (Programme) with Leonteq Securities AG acting as lead manager and are designed to produce financial returns analogous to those of traditional structured investment products. The Programme has been approved by the Shari’a Supervisory Board of Amanie Advisors Limited which has been appointed to advise IBDAA and Leonteq Securities AG on the Shari’a compliance of the Programme.

As part of Leonteq’s strategy to stay at the forefront of digitalisation and to create innovative digital solutions for its clients, IBDAA has now been enabled as a new issuer on LYNQS for Shari’a-compliant products with a minimum issuance size of USD 50,000. In addition, Leonteq has created a dedicated platform for the Middle East which exclusively offers Shari’a-compliant investment ideas and products issued by IBDAA.

Alessandro Ricci, Head Investment Solutions at Leonteq, stated: “We are very pleased to add IBDAA as a new issuer on our multi-issuer platform. This makes LYNQS the first digital tool globally to offer Shari’a-compliant products with a competitive minimum subscription size. Today we take a further step in advancing our capabilities in Islamic finance to better serve our growing franchise in the Middle East.”

Under the Programme, Leonteq’s platform allows investors to benefit from a short time-to-market and access to a large array of asset classes, currencies and payoffs, including yield enhancement, capital protection and participation. 

LEONTEQ

Leonteq is a Swiss fintech company with a leading marketplace for structured investment solutions. Based on proprietary modern technology, the company offers derivative investment products and services and predominantly covers the capital protection, yield enhancement and participation product categories. Leonteq acts as both a direct issuer of its own products and as a partner to other financial institutions. Leonteq further enables life insurance companies and banks to produce capital-efficient, unit-linked pension products with guarantees. The company has offices and subsidiaries in 13 countries across Europe, the Middle East and Asia. Leonteq AG has a BBB credit rating by Fitch Ratings, was assigned with an AA ESG rating by MSCI and is listed on the SIX Swiss Exchange (SIX: LEON). www.leonteq.com

 

Posted on

Nyxoah Appoints John Landry as Chief Financial Officer

Nyxoah Appoints John Landry as Chief Financial Officer

Current CFO, Loïc Moreau, to Transition into Role of President International

Mont-Saint-Guibert, Belgium – November 4, 2024, 10:45pm CET / 4:45pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced the appointment of John Landry as Chief Financial Officer (CFO), effective November 4, 2024. This strategic appointment, in combination with the recent move to the United States of CEO Olivier Taelman, strengthens the Company’s focus on the U.S. market.

Mr. Landry brings over two decades of financial leadership experience in the healthcare and medtech sectors, with a proven track record of driving growth and operational efficiency in public and private companies. Most recently, he served as CFO at Vapotherm Inc., where he played an instrumental role in executing financial strategies that supported significant revenue growth and market share expansion in the U.S. market.

“We are delighted to welcome John to Nyxoah. His deep financial expertise and extensive experience in the U.S. healthcare landscape in combination with his strong investor relations experience will be invaluable as we accelerate our growth in this critical market,” said Olivier Taelman, CEO of Nyxoah. “John’s leadership will help us further optimize our financial strategies and drive operational efficiencies as we prepare Genio for commercialization in the US.”

Additionally, Nyxoah announces that Loïc Moreau, currently CFO, will transition into the newly created role of President International. In this capacity, Mr. Moreau will spearhead Nyxoah’s global expansion efforts, focusing on strengthening the Company’s presence in key international markets.

This announcement reflects Nyxoah’s commitment to building a strong, diversified leadership team to support its ambitious growth objectives.

About Nyxoah
Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnea (OSA). We are a medical technology company that develops breakthrough treatment alternatives for OSA through neuromodulation. Our first innovation is Genio®, a battery-free hypoglossal neuromodulation device that is inserted through a single incision under the chin and controlled by a wearable. Through our commitment to innovation and clinical evidence, we have shown best-in-class outcomes for reducing OSA burden.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

FORWARD-LOOKING STATEMENTS

Certain statements, beliefs and opinions in this press release are forward-looking, reflecting Nyxoah’s current expectations and beliefs regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and potential receipt of FDA approval and entrance into the U.S. market. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of Nyxoah’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that Nyxoah files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, Nyxoah expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither Nyxoah nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:

Nyxoah
Loïc Moreau
IR@nyxoah.com

For Media
In United States
FINN Partners – Glenn Silver
glenn.silver@finnpartners.com

In Belgium/France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be

In International/Germany
MC Services – Anne Hennecke
nyxoah@mc-services.eu

Attachment

GlobeNewswire Distribution ID 1001011263

Recent Post